CambiaLabs Projects

BioSentinel (a.k.a BioIndicators)

This project was created to provide non-disruptive, nondestructive, in vivo management modules that farmers and/or various agricultural communities could access cost-free through the BioForge and a BiOS license. The modules are designed to harness the creativity and ingenuity of local communities to assemble, test, and selectively adopt these protocols according to their needs and wishes.

GUSPlus™ 

GUSPlus is a new reporter gene for use in molecular biology and plant transformation.

Transactivation 

Use of transactivator cassettes may enable precisely-controlled gene expression while getting around many promoter patents.

Telomerase

Cancer Diagnostics and Therapeutics. Built around the seminal work of Cambia's former Chief Scientist Andrzej Kilian, the many splice variants of the catalytic subunit of human telomerase present intriguing possibilities.

Cowpea Transformation 

TransBacter transformation of cowpea may lead to insect resistant crops.

TransBacter™

TransBacter is a new method of gene transfer for plants - or indeed any eukaryotic organism - using bacterial species outside the genus Agrobacterium. TransBacter is designed to be a work-around to the many patents covering Agrobacterium transformation and thus aims to overcome the current IP restrictions. It also has some technical advantages to Agrobacterium.

Legacy pCAMBIA Vectors

Developing new vector technologies aimed at making DNA construction and reporter gene fusions less cumbersome.

Apomixis (Egg Apparatus-Specific Enhancer) 

Clonal reproduction of plants via seed, known as apomixis, has the potential to change plant breeding technology. 

Diversity-Arrays (DArT™) 

DArT, or diversity arrays, is a technology developed by CAMBIA that enables researchers to analyze plant and animal genomes.

From the labs 

Get materials here, download documentation, contact the lab team.

Ordering CAMBIA materials

Please visit the CAMBIA Materials and Methods page to view and request available materials.

Please email any specific queries to Dr. Osmat Azzam Jefferson.

If you wish to execute a license for the use of materials, please contact us at licenses@cambia.org

We are currently reorganizing our website so please accept our apology if you can not access some links or attached protocols.  We appreciate your patience

Comments (0)